{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:11:54Z","timestamp":1789081914856,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58974-1","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T09:04:32Z","timestamp":1782032672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of surgical extent with survival in locally advanced gallbladder cancer based on propensity score matching"],"prefix":"10.1038","volume":"16","author":[{"given":"Jin","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"58974_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ijc.32863","volume":"4","author":"A Miranda-Filho","year":"2020","unstructured":"Miranda-Filho, A. et al. Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends. Int. J. Cancer 4, 978\u2013989 (2020).","journal-title":"Int. J. Cancer"},{"key":"58974_CR2","volume":"8","author":"SA Halaseh","year":"2022","unstructured":"Halaseh, S. A., Halaseh, S. & Shakman, R. A review of the etiology and epidemiology of gallbladder cancer: What You need to know. Cureus 8, e28260 (2022).","journal-title":"Cureus"},{"key":"58974_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/jso.27450","volume":"6","author":"S Vuthaluru","year":"2023","unstructured":"Vuthaluru, S., Sharma, P., Chowdhury, S. & Are, C. Global epidemiological trends and variations in the burden of gallbladder cancer. J. Surg. Oncol. 6, 980\u2013988 (2023).","journal-title":"J. Surg. Oncol."},{"key":"58974_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"1","author":"JC Roa","year":"2022","unstructured":"Roa, J. C. et al. Gallbladder Cancer. Nat. Rev. Disease Primers. 1, 69 (2022).","journal-title":"Nat. Rev. Disease Primers."},{"key":"58974_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2018.11815","volume":"12","author":"I Baiu","year":"2018","unstructured":"Baiu, I. & Visser, B. Gallbladder cancer. JAMA 12, 1294 (2018).","journal-title":"JAMA"},{"key":"58974_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"4","author":"MA Schmidt","year":"2019","unstructured":"Schmidt, M. A., Marcano-Bonilla, L. & Roberts, L. R. Gallbladder cancer: Epidemiology and genetic risk associations. Chin. Clin. Oncol. 4, 31 (2019).","journal-title":"Chin. Clin. Oncol."},{"key":"58974_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4143\/crt.2014.308","volume":"3","author":"JO Park","year":"2015","unstructured":"Park, J. O. et al. Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review. Cancer Res. Treat. 3, 343\u2013361 (2015).","journal-title":"Cancer Res. Treat."},{"key":"58974_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.18.00050","volume":"8","author":"J Edeline","year":"2019","unstructured":"Edeline, J. et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A randomized phase III study. J. Clin. Oncol. 8, 658\u2013667 (2019).","journal-title":"J. Clin. Oncol."},{"key":"58974_CR9","doi-asserted-by":"crossref","unstructured":"Marcinakl, C. T. & Abbott, D. E. Gallbladder cancer. Cancer treatment and research. 147\u201363 (2024).","DOI":"10.1007\/978-3-031-61238-1_8"},{"key":"58974_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/cco.2019.06.06","volume":"4","author":"RW Krell","year":"2019","unstructured":"Krell, R. W. & Wei, A. C. Gallbladder cancer: Surgical management. Chin. Clin. Oncol. 4, 36 (2019).","journal-title":"Chin. Clin. Oncol."},{"key":"58974_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","volume":"4","author":"J Shindoh","year":"2015","unstructured":"Shindoh, J. et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: An international multicenter study. Ann. Surg. 4, 733\u2013739 (2015).","journal-title":"Ann. Surg."},{"key":"58974_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21141","author":"A Duffy","year":"2008","unstructured":"Duffy, A. et al. Gallbladder cancer (GBC): 10-year experience at memorial sloan-kettering cancer centre (MSKCC). J. Surg. Oncol. https:\/\/doi.org\/10.1002\/jso.21141 (2008).","journal-title":"J. Surg. Oncol."},{"key":"58974_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MCG.0b013e3182703409","volume":"5","author":"H Lim","year":"2013","unstructured":"Lim, H. et al. Prognostic factors in patients with gallbladder cancer after surgical resection: Analysis of 279 operated patients. J. Clin. Gastroenterol. 5, 443\u2013448 (2013).","journal-title":"J. Clin. Gastroenterol."},{"key":"58974_CR14","volume-title":"SEER Program Coding and Staging Manual 2016","author":"M Adamo","year":"2016","unstructured":"Adamo, M., Dickie, L. & Ruhl, J. SEER Program Coding and Staging Manual 2016 (National Cancer Institute, 2016)."},{"key":"58974_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5984","author":"PC Austin","year":"2014","unstructured":"Austin, P. C. The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments. Stat. Med. https:\/\/doi.org\/10.1002\/sim.5984 (2014).","journal-title":"Stat. Med."},{"key":"58974_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.09.004","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.004 (2021).","journal-title":"Cancer Lett."},{"key":"58974_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.2679","volume":"1","author":"W Mao","year":"2020","unstructured":"Mao, W., Deng, F., Wang, D., Gao, L. & Shi, X. Treatment of advanced gallbladder cancer: A SEER-based study. Cancer Med-Us. 1, 141\u2013150 (2020).","journal-title":"Cancer Med-Us."},{"key":"58974_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1500091","author":"R Li","year":"2024","unstructured":"Li, R. et al. Comparison of treatment models for single primary advanced gallbladder cancer. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1500091 (2024).","journal-title":"Front. Immunol."},{"key":"58974_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s005340100017","volume":"6","author":"I Endo","year":"2001","unstructured":"Endo, I. et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J. Hepatobiliary Pancreat. Surg. 6, 505\u2013510 (2001).","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"58974_CR20","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1245\/s10434-021-09626-3","volume":"5","author":"EA Vega","year":"2021","unstructured":"Vega, E. A. et al. Conditional recurrence-free survival after oncologic extended resection for gallbladder cancer: An international multicenter analysis. Ann. Surg. Oncol. 5, 2675\u20132682 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"58974_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2025.102080","volume":"7","author":"AM Chirban","year":"2025","unstructured":"Chirban, A. M. et al. Advanced gallbladder cancer (T3 and T4): Insights from an international multicenter study. J. Gastrointest. Surg. 7, 102080 (2025).","journal-title":"J. Gastrointest. Surg."},{"key":"58974_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1245\/s10434-020-08858-z","volume":"2","author":"H Kuipers","year":"2021","unstructured":"Kuipers, H. et al. extended resections for advanced gallbladder cancer: Results from a nationwide cohort study. Ann. Surg. Oncol. 2, 835\u2013843 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"58974_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1477-2574.2012.00544.x","volume":"12","author":"MJ Kang","year":"2012","unstructured":"Kang, M. J., Song, Y., Jang, J., Han, I. W. & Kim, S. Role of radical surgery in patients with stage IV gallbladder cancer. HPB (Oxford) 12, 805\u2013811 (2012).","journal-title":"HPB (Oxford)"},{"key":"58974_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s005340100018","volume":"6","author":"S Kondo","year":"2001","unstructured":"Kondo, S. et al. Five-year survivors after aggressive surgery for stage IV gallbladder cancer. J. Hepatobiliary Pancreat. Surg. 6, 511\u2013517 (2001).","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"58974_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s11605-007-0181-4","volume":"8","author":"M Kai","year":"2007","unstructured":"Kai, M. et al. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J. Gastrointest. Surg. 8, 1025\u20131032 (2007).","journal-title":"J. Gastrointest. Surg."},{"key":"58974_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/bjs.11088","volume":"5","author":"T Mizuno","year":"2019","unstructured":"Mizuno, T. et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br. J. Surg. 5, 626\u2013635 (2019).","journal-title":"Br. J. Surg."},{"key":"58974_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/000313481508100623","volume":"6","author":"M Ercan","year":"2015","unstructured":"Ercan, M. et al. The rationality of resectional surgery and palliative interventions in the management of patients with gallbladder cancer. Am. Surg. 6, 591\u2013599 (2015).","journal-title":"Am. Surg."},{"key":"58974_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"6","author":"MN Mavros","year":"2014","unstructured":"Mavros, M. N., Economopoulos, K. P., Alexiou, V. G. & Pawlik, T. M. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. Jama Surg. 6, 565\u2013574 (2014).","journal-title":"Jama Surg."},{"key":"58974_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","volume":"9","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras, D. I. et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: Considering alternative treatment approaches. Jama Surg. 9, 823\u2013831 (2020).","journal-title":"Jama Surg."},{"key":"58974_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103328","author":"AA Azizi","year":"2021","unstructured":"Azizi, A. A., Lamarca, A., McNamara, M. G. & Valle, J. W. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103328 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"58974_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"14","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 14, 1273\u20131281 (2010).","journal-title":"N. Engl. J. Med."},{"key":"58974_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/cco.2019.08.14","volume":"4","author":"M Javle","year":"2019","unstructured":"Javle, M., Zhao, H. & Abou-Alfa, G. K. Systemic therapy for gallbladder cancer. Chin. Clin. Oncol. 4, 44 (2019).","journal-title":"Chin. Clin. Oncol."},{"key":"58974_CR33","first-page":"262","volume":"5","author":"A Ramaswamy","year":"2017","unstructured":"Ramaswamy, A. et al. Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: A match pair analysis. J. Hepato-Bil-Pan Sci. 5, 262\u2013267 (2017).","journal-title":"J. Hepato-Bil-Pan Sci."},{"key":"58974_CR34","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2217\/fon.14.308","volume":"10","author":"B Sirohi","year":"2015","unstructured":"Sirohi, B. et al. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. (London, England). 10, 1501\u20131509 (2015).","journal-title":"Future Oncol. (London, England)."},{"key":"58974_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.977963","author":"Z Yang","year":"2022","unstructured":"Yang, Z. et al. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.977963 (2022).","journal-title":"Front. Oncol."},{"key":"58974_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12664-021-01182-8","volume":"6","author":"S Singh","year":"2021","unstructured":"Singh, S. et al. Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy\u2014A novel approach. Indian J. Gastroenterol. 6, 580\u2013589 (2021).","journal-title":"Indian J. Gastroenterol."},{"key":"58974_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.21037\/hbsn-20-846","volume":"4","author":"X Cui","year":"2021","unstructured":"Cui, X. et al. Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen. Hepatobil. Surg. Nutr. 4, 498\u2013506 (2021).","journal-title":"Hepatobil. Surg. Nutr."},{"key":"58974_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ejso.2021.09.002","volume":"2","author":"SK Kamarajah","year":"2022","unstructured":"Kamarajah, S. K. et al. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer a population-based cohort study. Eur. J. Surg. Oncol. 2, 425\u2013434 (2022).","journal-title":"Eur. J. Surg. Oncol."},{"key":"58974_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3857\/roj.2017.00388","volume":"4","author":"TG Kim","year":"2017","unstructured":"Kim, T. G. Patterns of initial failure after resection for gallbladder cancer: Implications for adjuvant radiotherapy. Radiat. Oncol. J. 4, 359\u2013367 (2017).","journal-title":"Radiat. Oncol. J."},{"key":"58974_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21037\/cco.2019.08.12","volume":"4","author":"V Verma","year":"2019","unstructured":"Verma, V. & Crane, C. H. Contemporary Perspectives On the Use of Radiation Therapy for Locally Advanced Gallbladder Cancer. Chin. Clin. Oncol. 4, 41 (2019).","journal-title":"Chin. Clin. Oncol."},{"key":"58974_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/jcrt.JCRT_1568_20","volume":"1","author":"S Sinha","year":"2022","unstructured":"Sinha, S. et al. Radiotherapy for locally advanced unresectable gallbladder cancer\u2014A way forward: Comparative study of chemotherapy versus chemoradiotherapy. J. Cancer Res. Ther. 1, 147\u2013151 (2022).","journal-title":"J. Cancer Res. Ther."},{"key":"58974_CR42","volume":"6","author":"R Engineer","year":"2019","unstructured":"Engineer, R. et al. A Phase III Randomised Clinical Trial of Perioperative Therapy (Neoadjuvant Chemotherapy Versus Chemoradiotherapy) in Locally Advanced Gallbladder Cancers (POLCAGB): Study Protocol. BMJ Open 6, e28147 (2019).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58974-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:58:38Z","timestamp":1789081118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58974-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58974-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data utilized in this study have been sourced exclusively from publicly accessible databases. Consequently, ethical review is not required for the information presented.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical information and data used in this SEER study were all downloaded from a public database. Informed consent was waived.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28398"}}